Wenping Gong Selected Research

Rocky Mountain Spotted Fever (Sao Paulo Typhus)

12/2017	Th1 epitope peptides induce protective immunity against Rickettsia rickettsii infection in C3H/HeN mice.
2/2015	Enhanced protection against Rickettsia rickettsii infection in C3H/HeN mice by immunization with a combination of a recombinant adhesin rAdr2 and a protein fragment rOmpB-4 derived from outer membrane protein B.
4/2014	Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice.
1/2014	Identification of novel surface-exposed proteins of Rickettsia rickettsii by affinity purification and proteomics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenping Gong Research Topics

Disease

13	Tuberculosis (Tuberculoses) 07/2022 - 10/2017
9	Infections 07/2022 - 11/2013
6	COVID-19 07/2022 - 01/2021
4	Rocky Mountain Spotted Fever (Sao Paulo Typhus) 12/2017 - 01/2014
3	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
3	Spotted Fever Group Rickettsiosis (Rickettsialpox) 01/2016 - 11/2013
3	Q Fever (Fever, Q) 01/2015 - 01/2014
1	Pathologic Processes 10/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 06/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Diabetes Mellitus 01/2022
1	Latent Tuberculosis 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Hyperglycemia 01/2022
1	Extensively Drug-Resistant Tuberculosis 09/2021
1	Coinfection 01/2018
1	Necrosis 01/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Brucellosis (Malta Fever) 12/2014
1	Mycoplasma Pneumonia 12/2014
1	Rickettsia Infections 01/2013

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 07/2022 - 01/2013
5	Peptides (Polypeptides)IBA 01/2022 - 01/2014
4	BCG Vaccine FDA Link 07/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 02/2015 - 01/2014
3	Tuberculosis VaccinesIBA 01/2022 - 01/2020
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2015 - 11/2013
3	AntigensIBA 02/2015 - 11/2013
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2017
2	EpitopesIBA 12/2017 - 01/2014
2	Immunoglobulin G (IgG)IBA 02/2015 - 01/2015
1	Sulfur DioxideIBA 10/2022
1	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 06/2022
1	Verapamil (Calan)FDA LinkGeneric 05/2022
1	Interleukin-12 (IL 12)IBA 05/2022
1	CalciumIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Protective AgentsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 09/2021
1	Therapeutic UsesIBA 01/2019
1	DNA VaccinesIBA 01/2019
1	MucinsIBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	InterferonsIBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	CytokinesIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Subunit VaccinesIBA 12/2014
1	Recombinant ProteinsIBA 11/2013
1	Indicators and Reagents (Reagents)IBA 01/2013

Therapy/Procedure

2	Immunotherapy 07/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2021